ABSTRACT Here, we report the draft genome sequence of Faecalimonas umbilicata JCM 30896 T , an acetate-producing bacterium isolated from human feces. The genomic analysis reveals genes for acetate and vitamin B 12 synthesis and will facilitate the study of the role of this strain in the human gut.
A cetate is one of the metabolic end products of anaerobic fermentation. Butyrateproducing bacteria, such as Faecalibacterium prausnitzii and Roseburia spp., can be net utilizers of acetate (1) . The butyrate formed by the above-mentioned acetateconsumers has important roles in colonic health (1) . Recently, we isolated a new acetate-producing bacterium, Faecalimonas umbilicata JCM 30896 T , from a fecal sample from a healthy Japanese man (2) . This species is a member of the family Lachnospiraceae. Anaerobic bacteria affiliated with the family Lachnospiraceae make up the majority of highly prevalent bacteria in the human intestinal tract (3). We analyzed the draft genome sequence of F. umbilicata JCM 30896 T to improve our understanding of the physiology and potential health contribution of this strain in the human gut.
F. umbilicata JCM 30896 T was grown on Eggerth-Gagnon agar (Merck) supplemented with 5% (vol/vol) horse blood for 4 days at 37°C under a H 2 -CO 2 -N 2 (1:1:8, by volume) gas mixture. Total genomic DNA was extracted from F. umbilicata JCM 30896 T using a Genomic-tip 100/G kit (Qiagen). Labiase (5.0 mg/ml; Cosmo Bio) was used to lyse bacterial cells. A whole-genome shotgun library was constructed using a SMRTbell template prep kit 1.0 (Pacific Biosciences), followed by single-molecule real-time (SMRT) sequencing conducted on the PacBio RS II sequencing system (Pacific Biosciences) by Takara. A total of 97,745 reads (311-fold coverage) with an average length of 13,372 bp were assembled de novo using Hierarchical Genome Assembly Process version 3.0 (HGAP3.0) in SMRT Analysis version 2.3.0 (4), resulting in 8 contigs with an N 50 value of 1,731,485 bp. The default settings for genome assembly were used. This assembly resulted in a draft genome sequence of 3,262,821 bp with a GϩC content of 41.6%. Analysis of the genome sequences was performed using the DDBJ Fast Annotation and Submission Tool (DFAST; https://dfast.nig.ac.jp/) (5). A total of 3,210 protein-coding sequences, 60 tRNAs, and 18 rRNAs were detected.
The genome of F. umbilicata JCM 30896 T contained genes involved in acetate synthesis, such as formate acetyltransferase (EC 2.3.1.54), phosphotransacetylase (EC 2.3.1.8), and acetate kinase (EC 2.7.2.1). In addition, F. umbilicata JCM 30896 T was predicted to possess a vitamin B 12 biosynthesis pathway. Vitamin B 12 is an important cofactor for a variety of enzymes. In the systematic genome assessment of B vitamin biosynthesis, vitamin B 12 biosynthesis was present in 42% of the genomes of 256 common human gut bacteria (6) . Furthermore, nearly half of the Firmicutes genomes (43%; 56/130) were predicted to synthesize vitamin B 12 (6) . Recently, true bidirectional metabolic cross-feeding dependent on vitamin B 12 was observed between the mucin-degrading bacterium Akkermansia muciniphila and the butyrate-producing bacterium Eubacterium hallii (7) . The production of vitamin B 12 and acetate by F. umbilicata might be beneficial for growth with other bacteria lacking the vitamin B 12 biosynthesis pathway, such as A. muciniphila (8) , and production of butyrate by butyrate-producing bacteria, such as F. prausnitzii.
The genome sequence will facilitate further studies of the beneficial role of this strain in the human gut.
Data availability. This whole-genome shotgun project has been deposited in DDBJ/ENA/GenBank under the accession no. BHEO00000000. The version described in this paper is the first version, BHEO01000000.
